MIT Corporation life member and biotech pioneer Henri Termeer dies at 71
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Termeer built Genzyme from a startup into a biotech powerhouse, while becoming an innovator in rare-disease drug development.
Study at MIT Medical finds most parents are capable of performing the test.
Former Google CEO, now chairman of parent company Alphabet, speaks to students as part of fireside chat with CSAIL Director Daniela Rus.
Senior Tiffany Yeh explores health care and poverty through working abroad, and cultivates her love of music while at home.
Seed funding from the MIT Sandbox Innovation Fund helped Multiply Labs' founders launch their personalized dietary supplement startup.
By measuring this emerging vital sign, CSAIL system could help monitor and diagnose health issues like cognitive decline and cardiac disease.
Industry leaders, patient advocates, and policymakers collaborate to lower barriers to potentially curative treatments.
Microfluidic device isolates plasma cells from blood rather than bone marrow.
Advisor to $1.4 billion state plan sees health care as foundation for “Vital Brooklyn.”
Startup develops app to detect irregular heartbeats that can cause strokes.
Committee outlines strategies for building student trust in support systems, encouraging help-seeking, and providing coordinated, compassionate care.
Eight student teams pitched novel inventions at MIT Sloan Healthcare Innovations Prize competition.